Cargando…
Oxybutynin as an alternative treatment for hyperhidrosis
Hyperhidrosis is the excessive production of sweating, which can be primary and focal or secondary to various pathologies. The exact cause of primary focal hyperhidrosis is still unknown, although a genetic basis is recognized, and its prevalence varies from 1% to 2.8%. The most affected sites are t...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Dermatologia
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429108/ https://www.ncbi.nlm.nih.gov/pubmed/28538882 http://dx.doi.org/10.1590/abd1806-4841.201755126 |
_version_ | 1783235963545190400 |
---|---|
author | Delort, Sergio Marchi, Evaldo Corrêa, Marcos Antônio |
author_facet | Delort, Sergio Marchi, Evaldo Corrêa, Marcos Antônio |
author_sort | Delort, Sergio |
collection | PubMed |
description | Hyperhidrosis is the excessive production of sweating, which can be primary and focal or secondary to various pathologies. The exact cause of primary focal hyperhidrosis is still unknown, although a genetic basis is recognized, and its prevalence varies from 1% to 2.8%. The most affected sites are the armpits, palms, soles and face. It causes much discomfort, affects the quality of life, and is estimated to be undervalued by health professionals. Many treatment options are proposed, both clinical and surgical. The aim of this review is to focus on the treatment of hyperhidrosis with oxybutynin, an anticholinergic drug originally used to control overactive bladder. |
format | Online Article Text |
id | pubmed-5429108 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Sociedade Brasileira de Dermatologia |
record_format | MEDLINE/PubMed |
spelling | pubmed-54291082017-05-17 Oxybutynin as an alternative treatment for hyperhidrosis Delort, Sergio Marchi, Evaldo Corrêa, Marcos Antônio An Bras Dermatol Review Hyperhidrosis is the excessive production of sweating, which can be primary and focal or secondary to various pathologies. The exact cause of primary focal hyperhidrosis is still unknown, although a genetic basis is recognized, and its prevalence varies from 1% to 2.8%. The most affected sites are the armpits, palms, soles and face. It causes much discomfort, affects the quality of life, and is estimated to be undervalued by health professionals. Many treatment options are proposed, both clinical and surgical. The aim of this review is to focus on the treatment of hyperhidrosis with oxybutynin, an anticholinergic drug originally used to control overactive bladder. Sociedade Brasileira de Dermatologia 2017 /pmc/articles/PMC5429108/ /pubmed/28538882 http://dx.doi.org/10.1590/abd1806-4841.201755126 Text en ©2017 by Anais Brasileiros de Dermatologia http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium provided the original work is properly cited. |
spellingShingle | Review Delort, Sergio Marchi, Evaldo Corrêa, Marcos Antônio Oxybutynin as an alternative treatment for hyperhidrosis |
title | Oxybutynin as an alternative treatment for hyperhidrosis |
title_full | Oxybutynin as an alternative treatment for hyperhidrosis |
title_fullStr | Oxybutynin as an alternative treatment for hyperhidrosis |
title_full_unstemmed | Oxybutynin as an alternative treatment for hyperhidrosis |
title_short | Oxybutynin as an alternative treatment for hyperhidrosis |
title_sort | oxybutynin as an alternative treatment for hyperhidrosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429108/ https://www.ncbi.nlm.nih.gov/pubmed/28538882 http://dx.doi.org/10.1590/abd1806-4841.201755126 |
work_keys_str_mv | AT delortsergio oxybutyninasanalternativetreatmentforhyperhidrosis AT marchievaldo oxybutyninasanalternativetreatmentforhyperhidrosis AT correamarcosantonio oxybutyninasanalternativetreatmentforhyperhidrosis |